Hyman Phelps and McNamara
 
Firm Publicatons
 

Personalized Medicine: Improving the Regulatory Pathway
May 2011

Personalized medicine has provided both great hope and great hype. Even partial realization of the potential of personalized medicine could significantly change medicine by enabling the right patients to get the right medicine at the right time in the right dose.

Yet while new diagnostic tools have led to some important advances in healthcare, the expected revolution has not arrived. So far, the Age of Personalized Medicine has not dawned. However, a number of improvements need to be implemented for personalized medicine to lead to meaningful clinical advances.

Click here to view the full Regulatory Focus article

If you have any questions regarding the above information, please contact:
Jeffrey N. Gibbs (202) 737-4288 jgibbs@hpm.com